NCT06166277 Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
| NCT ID | NCT06166277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rush University Medical Center |
| Condition | Vasovagal Syncope |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.
Eligibility Criteria
Inclusion Criteria: * symptomatic vasovagal syncope or symptomatic bradyarrhythmia refractory to behavioral and medical measures * age \< 60 years Exclusion Criteria: * age \> 60 years * intra-/infra-Hisian AV block * intrinsic sinus node disease * history of supraventricular tachycardia * history of ventricular tachycardia * presence of structural heart disease related * prior history of catheter ablation * presence of inheritable arrhythmic conditions * orthostatic hypotension on HUTT test * abnormal thyroid function levels * Proven indication for permanent pacemaker implantation
Contact & Investigator
Tolga Aksu, MD
STUDY CHAIR
Yepedite University
Frequently Asked Questions
Who can join the NCT06166277 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Vasovagal Syncope. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06166277 currently recruiting?
Yes, NCT06166277 is actively recruiting participants. Contact the research team at alexander_mazur@rush.edu for enrollment information.
Where is the NCT06166277 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06166277 clinical trial?
NCT06166277 is sponsored by Rush University Medical Center. The principal investigator is Tolga Aksu, MD at Yepedite University. The trial plans to enroll 300 participants.